Bleeding and Thromboembolism After TBI in the Elderly: A Real Conundrum
JournalJournal of Surgical Research
PublisherAcademic Press Inc.
MetadataShow full item record
AbstractBackground: Elderly patients presenting with a traumatic brain injury (TBI) often have comorbidities that increase risk of thromboembolic (TE) disease and recurrent TBI. A significant number are on anticoagulant therapy at the time of injury and studies suggest that continuing anticoagulation can prevent TE events. Understanding bleeding, recurrent TBI, and TE risk after TBI can help to guide therapy. Our objectives were to 1) evaluate the incidence of bleeding, recurrent TBI, and TE events after an initial TBI in older adults and 2) identify which factors contribute to this risk. Methods: Retrospective analysis of Medicare claims between May 30, 2006 and December 31, 2009 for patients hospitalized with TBI was performed. We defined TBI for the index admission, and hemorrhage (gastrointestinal bleeding or hemorrhagic stroke), recurrent TBI, and TE events (stroke, myocardial infarction, deep venous thrombosis, or pulmonary embolism) over the following year using ICD-9 codes. Unadjusted incidence rates and 95% confidence intervals (CIs) were calculated. Risk factors of these events were identified using logistic regression. Results: Among beneficiaries hospitalized with TBI, incidence of TE events (58.6 events/1000 person-years; 95% CI 56.2, 60.8) was significantly higher than bleeding (23.6 events/1000 person-years; 95% CI 22.2, 25.1) and recurrent TBI events (26.0 events/1000 person-years; 95% CI 24.5, 27.6). Several common factors predisposed to bleeding, recurrent TBI, and TE outcomes. Conclusions: Among Medicare patients hospitalized with TBI, the incidence of TE was significantly higher than that of bleeding or recurrent TBI. Specific risk factors of bleeding and TE events were identified which may guide care of older adults after TBI. Copyright 2018 Elsevier Inc.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85057594881&doi=10.1016%2fj.jss.2018.10.021&partnerID=40&md5=de4cbd098821d9101dc752b2b03adbf4; http://hdl.handle.net/10713/10562
- Benefits and risks of anticoagulation resumption following traumatic brain injury.
- Authors: Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH
- Issue date: 2014 Aug
- Safety of Antidepressant Classes Used Following Traumatic Brain Injury Among Medicare Beneficiaries: A Retrospective Cohort Study.
- Authors: Albrecht JS, Rao V, Perfetto EM, Daniel Mullins C
- Issue date: 2018 Aug
- Venous thromboembolic events in critically ill traumatic brain injury patients.
- Authors: Skrifvars MB, Bailey M, Presneill J, French C, Nichol A, Little L, Duranteau J, Huet O, Haddad S, Arabi Y, McArthur C, Cooper DJ, Bellomo R, EPO-TBI investigators and the ANZICS Clinical Trials Group.
- Issue date: 2017 Mar
- Therapeutic anticoagulation in patients with traumatic brain injury.
- Authors: Matsushima K, Inaba K, Cho J, Mohammed H, Herr K, Leichtle S, Zada G, Demetriades D
- Issue date: 2016 Sep
- How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury.
- Authors: Olufajo OA, Yorkgitis BK, Cooper Z, Rios-Diaz A, Metcalfe D, Havens JM, Kelly E, Haider AH, Gates JD, Salim A
- Issue date: 2016 Jul